Herbal Product Standardization: Ensuring Safety and Efficacy for Biopharmaceutical Use in Asia and Australasia

Md Shahadat Hossan ^1*, Md Shamsuddin Sultan Khan ^2*

Herbal products from Asia and Australasia hold biopharmaceutical potential, but standardization ensures safety, efficacy, and quality for integration into modern medicine.

Abstract

Herbal products, especially those from Asia and Australasia, have drawn much attention recently because of their potential for use in biopharmaceutical applications. Meanwhile, the extensive use of herbal items in the pharmaceutical sector raises questions about their effectiveness, safety, and quality. This abstract covers the critical requirement for herbal product standardization to build reliable quality control procedures and guarantee the safety and effectiveness of these goods when used in biopharmaceuticals.In many Asian and Australasian cultures, herbal products have a long history of traditional use. They are famous for their medicinal benefits and capacity to yield new bioactive chemicals. As a result, incorporating these natural treatments into contemporary medicine is gaining popularity. Standardization is crucial due to their inherent diversity caused by climate, soil types, and agriculture techniques. The importance of creating thorough standards for herbal goods that cover botanical identification, authentication, quality control, and regulatory compliance is highlighted in this abstract. Such guidelines are essential for guaranteeing the consistency of product efficacy and quality. They also serve as a foundation for evaluating safety, particularly when herbal medications are used with conventional pharmaceuticals. Collaboration between stakeholders, such as bearers of traditional knowledge, scientists, regulatory bodies, and business leaders, is necessary to form these standards. Furthermore, modern analytical methods like DNA barcoding, spectroscopy, and chromatography are extremely important in confirming the authenticity and caliber of herbal products.The herbal product business can provide pharmaceutical companies with a dependable and repeatable source of bioactive chemicals by putting strict quality control systems in place. This abstract emphasizes the significance of standardizing herbal products through research and development to maximize their potential for biopharmaceutical applications. To sum up, the Standardization of herbal products is crucial for maximizing the potential of botanical resources from Asia and Australia for biopharmaceutical use. It addresses quality, efficacy, and safety issues, ultimately making it easier to incorporate these natural therapies into contemporary medicine.

Keywords:  Herbal products,  Standardization,  Quality control,  Asia, Australasia

References

Bazala V. The Historical Development of Medicine in the Croatian lands. Zagreb: Croation Publishing Bibliographic Institute; 1943. p. 9-20.

Bercovitz, J., & Feldman, M. (2006). Entrepreneurial universities and technology transfer: A conceptual framework for understanding knowledge-based economic development. Journal of Technology Transfer, 31(1), 175-188.

Bresnen, M., Edelman, L., Newell, S., Scarbrough, H., & Swan, J. (2003). Social practices and the management of knowledge in project environments. International Journal of Project Management, 21(3), 157-166.

Chen, Hua-Xing, et al. “A review of the open charm and open bottom systems.” Reports on Progress in Physics 80.7 (2017): 076201.

Chesbrough, H. W. (2003). Open Innovation: The New Imperative for Creating and Profiting from Technology. Harvard Business Press.Carayannis, E. G., & Campbell, D. F. (2009). ‘Mode 3’ and ‘Quadruple Helix’: toward a 21st-century fractal innovation ecosystem. International Journal of Technology Management, 46(3-4), 201-234.

Cuerrier, A., Turner, N. J., Gomes, T. C., Garibaldi, A., & Downing, A. (2015). Cultural Keystone Places: Conservation and Restoration in Cultural Landscapes. Journal of Ethnobiology, 35(1), 125-148.

Dai, Y., Harinantenaina, L., Brodie, P. J., & Callmander, M. W. (2017). A Review of the Genus Dioscorea: Traditional Uses and Pharmacological Research. In: G. Ramawat & J. Mérillon (Eds.), Natural Products. Springer.

De Smet PAGM, Keller K, Hansel R, Chandler RF. Adverse Effects of Herbal Drugs: Springer-Verlag. Heidelberg 1997;129(3): 137-145.

Dervendzi V. Contemporary Treatment with Medicinal Plants. Skopje: Tabernakul; 1992. p. 5-43.

Ekor, M. (2014). The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety. Frontiers in Pharmacology, 4, 177.

 Ernst E, Schmidt K, Wider B. CAM research in Britain: The last 10 years. Complement Ther Clin Pract 2005;11:17-20.

European Medicines Agency. (2015). Guideline on quality of herbal medicinal products/traditional herbal medicinal products. Amsterdam: EMA.

Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000;9:105-12.

General guidelines for methodologies on research and evaluation of traditional medicine Geneva: World Health Organization; 2000 (WHO/EDM/TRM/2000.1).

 Goyal M, Sasmal D, Nagori BP. Ayurveda the Ancient Science of Healing: An Insight. In: Vallisuta O, Olimat SM, editors. Drug Discovery Research in Pharmacognosy. 1st ed. Rijeka, Croatia: Tech Publication; 2012.

Immel, Stefan, and Frieder W. Lichtenthaler. “The hydrophobic topographies of amylose and its blue iodine complex.” Starch-Stärke 52.1 (2000): 1-8.

 Israili AH. Humoral theory of unani tibb. Indian J Hist Sci 1981;16:95-9.

Jaiswal, Sunil Kumar, et al. “Curcumin mediated attenuation of carbofuran induced oxidative stress in rat brain.” Biochemistry Research International 2016 (2016).

Katic R. Medicine en Serbie au Moyen Age. Beograd: Scientific work; 1958. p. 7-36.

Mukherjee PW. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. New Delhi, India: Business Horizons Publishers; 2002.

Nikolovski B. Essays on the History of Health Culture in Macedonia. Skopje: Macedonian Pharmaceutical Association; 1995. p. 17-27.

Petersen, Poul Erik, and Michael A. Lennon. “Effective use of fluorides for the prevention of dental caries in the 21st century: the WHO approach.” Community dentistry and oral epidemiology 32.5 (2004): 319-321.

Pharmacopoeia of the People’s Republic of China. (2020). General Rules for Pharmaceutical Preparations in Chinese Pharmacopoeia. Beijing: China Medical Science Press.

Pieroni, A. (2008). Local plant resources in the ethnobotany of Theth, a village in the Northern Albanian Alps. Genetic Resources and Crop Evolution, 55(8), 1197-1214

Quality control methods for herbal materials. Geneva: World Health Organization; 2011

Raymond, E. S. (1999). The Cathedral and the Bazaar: Musings on Linux and Open Source by an Accidental Revolutionary. O’Reilly Media.Saxenian, A. (1994). Regional Advantage: Culture and Competition in Silicon Valley and Route 128. Harvard University Press.

Rodrigues E, Barnes J. Pharmacovigilance of herbal medicines: The potential contributions of ethnobotanical and ethnopharmacological studies. Drug Saf 2013;36:1-2.

Rogers K, editor. The 100 Most Influential Scientists of All Time. 1st ed. New York: Britannica Educational Publishing in Association with Rosen Educational Services; 2010.

Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K. M., & Latha, L. Y. (2011). Extraction, Isolation and Characterization of Bioactive Compounds from Plants’ Extracts. African Journal of Traditional, Complementary and Alternative Medicines, 8(1), 1-10.

Saul, Nicholas. Gypsies and Orientalism in German literature and anthropology of the long nineteenth century. MHRA, 2007.

Shahzad, Naiyer, et al. “Phytosterols as a natural anticancer agent: Current status and future perspective.” Biomedicine & Pharmacotherapy 88 (2017): 786-794.

Singh, Dave, et al. “Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019.” European Respiratory Journal 53.5 (2019).

 Smith JE. A brief history of herbal medicine. Inspired Times 2010;4:15.

The International Pharmacopoeia, seventh edition. Geneva: World Health Organization; 2017.

U.S. Food and Drug Administration 2011. Regulatory Framework of DSHEA of 1994

U.S. Food and Drug Administration. (2004). Guidance for Industry: Botanical Drug Products.

Welsh J and McClelland M. Genomic fingerprints produced by PCR with consensus tRNA gene primers: 9Nucleic Acids Res, 1991; 19:861-866

WHO good manufacturing practices (GMP): supplementary guidelines for the manufacture of herbal medicines. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: fortieth report. Geneva: World Health Organization; 2006

WHO guidelines for selecting marker substances of herbal origin for quality control of herbal medicines. In: WHO Expert Committee on Specification for Pharmaceutical Preparations: fiftyfirst report. Geneva: World Health Organization; 2017: Annex 1 (WHO Technical Report Series, No. 1003).

WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: World Health Organization; 2003.

WHO monographs on selected medicinal plants commonly used in the Newly Independent States (NIS). Geneva: World Health Organization; 2010.

WHO monographs on selected medicinal plants, volume 1. Geneva: World Health Organization; 1999.

WHO monographs on selected medicinal plants, volume 2. Geneva: World Health Organization; 2002.

WHO monographs on selected medicinal plants, volume 3. Geneva: World Health Organization; 2007.

WHO monographs on selected medicinal plants, volume 4. Geneva: World Health Organization; 2009.

World Health Organization – Traditional Medicine Strategy

World Health Organization. (2002). Traditional Medicine Strategy 2002-2005. Geneva: World Health Organization.

World Health Organization. (2013). WHO traditional medicine strategy: 2014-2023. World Health Organization.

World Health Organization. Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. Geneva, Switzerland: World Health Organization; 2004.

Zhou J, Ouedraogo M, Qu F, Duez P. Potential genotoxicity of traditional Chinese medicinal plants and phytochemicals: An overview. Phytother Res 2013;27:1745-55.